what to expect when starting semaglutide for weight loss How Know If Is Working: Signs and Timeline Semaglutide, also known as Ozempic,

Current evidence does not show that GLP-1 drugs inherently enhance performance in healthy, non-diabetic athletesthough they are being closely examined in weight-sensitive sports such as cycling, equestrian, wrestling, gymnastics and figure skating

[1] [5] Anti-emetic medications should only be used following clinical advice due to potential contraindications or interactions

Metabolic demands for L-Carnitine Can be divided into 3 categories Primary Secondary Functional shortage age dependent condition dependent Muscle (lamb) - 2.03 Muscle (beef) - 0.61 Muscle (pig) - 0.27 Heart (cattle) - 0.23 Muscle (poultry)- 0.09 Milk (cow) - 0.026 Liver (lamb) - 0.022 Salmon - 0.0006 Rice - 0.018 Eggs and peas - 0.008 Potatoes - 0.0003 Carrots/spinach - 0.000 Carnitine content of foods (mg/g) adopted Heinz Loster 2003/Rigault 2007 Infants (3 kg) Skeletal muscle 1.98 Liver 0.55 Heart 0.77 Plasma males 0.026 females 0.023 Adults (70 kg) Skeletal muscle 3.96 Liver 2.90 Heart 4.80 Brain 0.30 Total Carnitine, humans (umol/ml) L-Carnitine in Pet Food Varies by type of ingredients foods of animal origin blended with other ingredients processing such boiling, soaked, washing freezing and/or drying Not understood is bioavailability of natural forms of L-Carnitine It matters: bound vs free L-Carnitine -Oxidation + + L-Carnitine L-Carnitine Krebs-Cycle Respiration CoA CoA CoA CoA CoA CoA Fatty acid + + + L-Carnitine L-Carnitine Energy (ATP) L-Carnitine physiology and its role in energy production Cell Mitochondria Cytosol Glucose Pyruvate Acetyl CoA OAA TCA Citrate -kg L-Carnitine supplementation can influence total metabolism Pyruvate Carboxylase Glycogen -oxidation Fat + L-Carnitine Protein Amino Acids BCAADH (leucine, iso,) Roles of L-Carnitine in the body Convert fat into energy

The post points to patients with type 2 diabetes or weight-management goals who tolerate standard titration, have stable kidney function, no contraindicated comorbidities, and adequate injection confidence

Cardiovascular outcomes of semaglutide and tirzepatide for patients with type 2 diabetes in clinical practice

among those morbidly obese, 17 percent died